MX348303B - Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico. - Google Patents
Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico.Info
- Publication number
- MX348303B MX348303B MX2013003204A MX2013003204A MX348303B MX 348303 B MX348303 B MX 348303B MX 2013003204 A MX2013003204 A MX 2013003204A MX 2013003204 A MX2013003204 A MX 2013003204A MX 348303 B MX348303 B MX 348303B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- hyaluronic acid
- evaluation
- renal injury
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
- 206010061481 Renal injury Diseases 0.000 title abstract 3
- 229920002674 hyaluronan Polymers 0.000 title abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000011156 evaluation Methods 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38642110P | 2010-09-24 | 2010-09-24 | |
| PCT/US2011/053015 WO2012040592A1 (en) | 2010-09-24 | 2011-09-23 | Methods and compositions for the evaluation of renal injury using hyaluronic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013003204A MX2013003204A (es) | 2013-06-05 |
| MX348303B true MX348303B (es) | 2017-06-06 |
Family
ID=45874188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013003204A MX348303B (es) | 2010-09-24 | 2011-09-23 | Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130252264A1 (enExample) |
| EP (1) | EP2619231B1 (enExample) |
| JP (1) | JP2013541005A (enExample) |
| KR (1) | KR20140051099A (enExample) |
| CN (2) | CN103189394B (enExample) |
| AU (1) | AU2011305197B2 (enExample) |
| BR (1) | BR112013006631A2 (enExample) |
| CA (1) | CA2813011A1 (enExample) |
| EA (1) | EA201390294A1 (enExample) |
| ES (1) | ES2619617T3 (enExample) |
| MX (1) | MX348303B (enExample) |
| NZ (1) | NZ609126A (enExample) |
| WO (1) | WO2012040592A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2882767B1 (en) * | 2012-08-11 | 2023-07-12 | Astute Medical, Inc. | Evaluating renal injury using hyaluronic acid |
| CN119643878B (zh) * | 2024-12-25 | 2025-07-25 | 中国人民解放军总医院第一医学中心 | 一种检测肾脏纤维化相关疾病的生物标志物及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| JP2004208693A (ja) * | 2002-12-17 | 2004-07-29 | Sanyo Chem Ind Ltd | 抗ヒアルロン酸抗体、これを含む試薬キット、抗ヒアルロン酸抗体の製造法及びヒアルロン酸の測定法 |
| WO2005114186A1 (ja) * | 2004-05-20 | 2005-12-01 | Wako Pure Chemical Industries, Ltd. | ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法 |
| US20090285761A1 (en) * | 2008-04-18 | 2009-11-19 | Pharmacophotonics, Llc D/B/A Fast Diagnostics | Renal Function Analysis Method and Apparatus |
| WO2009146450A2 (en) * | 2008-05-30 | 2009-12-03 | Therapeutic Monitoring Services, L.L.C. | Methods for monitoring immunosuppressant drug levels, renal function, and hepatic function using small volume samples |
| US8673574B2 (en) * | 2008-08-21 | 2014-03-18 | Pxbiosciences Llc | Diagnosis and monitoring of renal failure using peptide biomarkers |
| NZ610356A (en) * | 2008-08-28 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US8501489B2 (en) * | 2008-09-26 | 2013-08-06 | University of Pittsburgh—of the Commonwealth System of Higher Education | Urinary biomarkers to predict long-term dialysis |
| EP2393937A4 (en) * | 2009-02-06 | 2012-08-08 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE |
| JP5763098B2 (ja) * | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
-
2011
- 2011-09-23 JP JP2013530362A patent/JP2013541005A/ja active Pending
- 2011-09-23 CA CA2813011A patent/CA2813011A1/en not_active Abandoned
- 2011-09-23 AU AU2011305197A patent/AU2011305197B2/en not_active Ceased
- 2011-09-23 EP EP11827625.2A patent/EP2619231B1/en not_active Not-in-force
- 2011-09-23 MX MX2013003204A patent/MX348303B/es active IP Right Grant
- 2011-09-23 BR BR112013006631A patent/BR112013006631A2/pt not_active IP Right Cessation
- 2011-09-23 NZ NZ609126A patent/NZ609126A/en not_active IP Right Cessation
- 2011-09-23 ES ES11827625.2T patent/ES2619617T3/es active Active
- 2011-09-23 EA EA201390294A patent/EA201390294A1/ru unknown
- 2011-09-23 WO PCT/US2011/053015 patent/WO2012040592A1/en not_active Ceased
- 2011-09-23 KR KR1020137010404A patent/KR20140051099A/ko not_active Ceased
- 2011-09-23 US US13/825,675 patent/US20130252264A1/en not_active Abandoned
- 2011-09-23 CN CN201180047897.8A patent/CN103189394B/zh not_active Expired - Fee Related
- 2011-09-23 CN CN201610569328.4A patent/CN106248921A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112013006631A2 (pt) | 2017-10-24 |
| NZ609126A (en) | 2015-05-29 |
| CN106248921A8 (zh) | 2017-07-21 |
| AU2011305197B2 (en) | 2015-06-11 |
| EP2619231A4 (en) | 2014-04-30 |
| ES2619617T3 (es) | 2017-06-26 |
| MX2013003204A (es) | 2013-06-05 |
| JP2013541005A (ja) | 2013-11-07 |
| EP2619231B1 (en) | 2016-12-21 |
| WO2012040592A1 (en) | 2012-03-29 |
| AU2011305197A1 (en) | 2013-05-02 |
| CN106248921A (zh) | 2016-12-21 |
| CA2813011A1 (en) | 2012-03-29 |
| CN103189394A (zh) | 2013-07-03 |
| EP2619231A1 (en) | 2013-07-31 |
| CN103189394B (zh) | 2016-08-17 |
| EA201390294A1 (ru) | 2013-09-30 |
| KR20140051099A (ko) | 2014-04-30 |
| US20130252264A1 (en) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011106746A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP2767833A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX336280B (es) | Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal. | |
| MX341191B (es) | Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal. | |
| EP3734280A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| NZ625423A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| TR201904386T4 (tr) | Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem. | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2011008323A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| NZ608384A (en) | Biomarkers of renal injury | |
| BR112013006683A2 (pt) | diagnóstico de câncer de mama | |
| HK1259001A1 (zh) | 癌症的预後和诊断方法 | |
| MX2019008260A (es) | Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c. | |
| MX361731B (es) | Método para diagnosticar cáncer y kit de diagnóstico usando medición de actividad de células nk. | |
| WO2016064877A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2014000283A (es) | Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. | |
| MX2014002030A (es) | Biomarcadores de carcinoma de celulas renales y usos de los mismos. | |
| MX2012003168A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. | |
| MX2012005218A (es) | Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal. | |
| WO2012006056A3 (en) | Ccr6 as a biomarker of alzheimer's disease | |
| WO2013066879A3 (en) | SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE | |
| NZ601648A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2011084548A3 (en) | Methods and compositions for detecting recessive familial fsgs and uses thereof | |
| WO2012006394A3 (en) | Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |